Stephen Hodi Clinical Oncology Society of Australia 2014 Annual Scientific Meeting

Abstracts this author is presenting:

• Long-term survival of ipilimumab-naïve patients with advanced melanoma (MEL) treated with nivolumab (anti-Programmed Death-1; anti-PD-1; BMS-936558; ONO-4538) in a phase I trial. — Poster discussion 2